Hypothesis

1 Matching Annotations

Jul 2024
www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov

GPAT3 is a potential therapeutic target to overcome sorafenib resistance in hepatocellular carcinoma

1
1. scibot 03 Jul 2024
  
  in Public
  
  RRID: CVCL_4972
  
  DOI: 10.7150/thno.92646
  
  Resource: (RRID:CVCL_4972)
  
  Curator: @evieth
  
  SciCrunch record: RRID:CVCL_4972
  
  What is this?
  
  RRID:CVCL_4972 DOI:10.7150/thno.92646
Visit annotations in context

Tags

DOI:10.7150/thno.92646

RRID:CVCL_4972

Annotators

scibot

URL

ncbi.nlm.nih.gov/pmc/articles/PMC11209725/